We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Monday
May 05
09:00 - 10:00
Business 1-2
Strategies to overcome radioresistance
Francesco Marampon, Italy;
Geoff Higgins, United Kingdom
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Radiobiology
Breast
09:00 - 09:07
Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue: TROD-GROG 006
Özüm Atasoy, Turkey
E25-1482
09:07 - 09:14
MMP11 is a regulator of prostate cancer radioresistance and a promising liquid biopsy marker of prostate cancer progression
Anna Dubrovska, Germany
E25-1678
09:14 - 09:21
Untargeted metabolomics reveals pyruvate kinase M (PKM) as potential radiosensitizer in triple-negative breast cancer cells
Sandra Classen, Germany
E25-2448
09:21 - 09:28
Micro-physio/pathological system on-chip as a preclinical model to replicate pancreatic tumor microenvironment for radiobiological applications
Sofia Tartaro, Italy
E25-2975
09:28 - 09:35
Oesophageal adenocarcinoma radiation resistance is shaped by therapy-associated genomic, epigenetic and transcriptomic evolution
Christopher Jones, United Kingdom
E25-4472
09:35 - 09:42
Microbeam Radiation Therapy (MRT) enhances tumour growth delay in a syngeneic mouse lung tumour model
Aleksandra Čolić, Germany
E25-3924
09:42 - 09:49
Effect of irradiation on Head and Neck Squamous Cell Carcinoma-derived CAF phenotype and function.
Kris Raaijmakers, The Netherlands
E25-2685